LakeShore Other Current Liab from 2010 to 2025
| LSBPW Stock | 0.06 0.02 41.24% |
Other Current Liabilities | First Reported 2010-12-31 | Previous Quarter 466.6 M | Current Value 262.3 M | Quarterly Volatility 130 M |
Check LakeShore Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LakeShore Biopharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 37.9 M, Interest Expense of 29.6 M or Selling General Administrative of 130.7 M, as well as many indicators such as Price To Sales Ratio of 1.07, Dividend Yield of 0.0 or PTB Ratio of 1.05. LakeShore financial statements analysis is a perfect complement when working with LakeShore Biopharma Valuation or Volatility modules.
LakeShore | Other Current Liab |
Latest LakeShore Biopharma's Other Current Liab Growth Pattern
Below is the plot of the Other Current Liab of LakeShore Biopharma Co, over the last few years. It is LakeShore Biopharma's Other Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in LakeShore Biopharma's overall financial position and show how it may be relating to other accounts over time.
| Other Current Liab | 10 Years Trend |
|
Other Current Liab |
| Timeline |
LakeShore Other Current Liab Regression Statistics
| Arithmetic Mean | 305,878,889 | |
| Coefficient Of Variation | 42.49 | |
| Mean Deviation | 62,455,901 | |
| Median | 321,134,996 | |
| Standard Deviation | 129,957,823 | |
| Sample Variance | 16889T | |
| Range | 616.8M | |
| R-Value | (0.05) | |
| Mean Square Error | 18056.9T | |
| R-Squared | 0 | |
| Significance | 0.87 | |
| Slope | (1,259,185) | |
| Total Sum of Squares | 253335.5T |
LakeShore Other Current Liab History
About LakeShore Biopharma Financial Statements
LakeShore Biopharma investors use historical fundamental indicators, such as LakeShore Biopharma's Other Current Liab, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in LakeShore Biopharma. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Other Current Liabilities | 466.6 M | 262.3 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for LakeShore Stock Analysis
When running LakeShore Biopharma's price analysis, check to measure LakeShore Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LakeShore Biopharma is operating at the current time. Most of LakeShore Biopharma's value examination focuses on studying past and present price action to predict the probability of LakeShore Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LakeShore Biopharma's price. Additionally, you may evaluate how the addition of LakeShore Biopharma to your portfolios can decrease your overall portfolio volatility.